
GC19130
EED226
Also known as N-(furan-2-ylmethyl)-8-(4-methylsulfonylphenyl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine
EED226 is a potent, selective, and orally bioavailable embryonic ectoderm development (EED) inhibitor with an IC50 of 22 nM
ChemicalCAS2083627-02-3MW369.4FormulaC17H15N5O3S
- CAS number
- 2083627-02-3
- Molecular weight
- 369.4
- Formula
- C17H15N5O3S
- Solubility
- DMSO : ≥ 29 mg/mL (78·51 mM);Water : < 0·1 mg/mL (insoluble)
- InChIKey
- DYIRSNMPIZZNBK-UHFFFAOYSA-N
- Catalogue number
- GC19130
- Brand
- GLPBIO
Computed properties PubChem CID 123132228 · XLogP 2.3 · TPSA 111 Ų · H-bond donors 1
- XLogP
- 2.3
- TPSA
- 111 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Rotatable bonds
- 5
- Heavy atoms
- 26
SMILES CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(N3C2=NN=C3)NCC4=CC=CO4
Computed descriptors from PubChem (CID 123132228), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il